These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6531551)

  • 1. [Piperacillin].
    Azanza Perea JR; Cuena Boy R; Rubio González A; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1984 Sep; 28(3):62-3. PubMed ID: 6531551
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drugs: piperacillin/tazobactam].
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):132-3. PubMed ID: 7711129
    [No Abstract]   [Full Text] [Related]  

  • 3. [Piperacillin/tazobactam--Tazocin. A penicillin-based alternative to 3rd generation cephalosporins and carbapenems].
    Schønning K; Tvede M
    Ugeskr Laeger; 2002 May; 164(20):2606-10. PubMed ID: 12043402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
    Kuck NA; Petersen PJ; Weiss WJ; Jacobus NV; Testa RT; Tally FP
    J Chemother; 1989 Jul; 1(4 Suppl):105-6. PubMed ID: 16312325
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
    File TM; Tan JS
    Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
    Vestweber KH; Grundel E
    Eur J Surg Suppl; 1994; (573):57-60. PubMed ID: 7524797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
    Li C; Kuti JL; Nightingale CH; Mansfield DL; Dana A; Nicolau DP
    J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin - another ureidopenicillin.
    Drug Ther Bull; 1983 Sep; 21(18):71-2. PubMed ID: 6628233
    [No Abstract]   [Full Text] [Related]  

  • 9. [Piperacillin in the treatment of severe infections of the urogenital system. Our experience].
    Fontana G; Sesia G; Laudi M; Chiaudano C
    Minerva Urol; 1983; 35(4):301-3. PubMed ID: 6674755
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
    Nord CE; Lahnborg G
    Eur J Surg Suppl; 1994; (573):45-9. PubMed ID: 7524795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
    Gatti M; Varoli O; Piscolla F
    J Chemother; 1989 Jul; 1(4 Suppl):103-4. PubMed ID: 16312324
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stability of the piperacillin and its pharmacokinetics in the saliva of normal individuals].
    Pase U; Miotti F
    G Stomatol Ortognatodonzia; 1983; 2(4):81-3. PubMed ID: 6590516
    [No Abstract]   [Full Text] [Related]  

  • 13. In-vitro evaluation of "piperacillin and tazobactum" combination in a tertiary-care hospital--a preliminary study.
    Kumari N; Mohapatra TM; Rai A; Bhattacharya SK
    Indian J Pathol Microbiol; 2006 Jan; 49(1):57-8. PubMed ID: 16625981
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of piperacillin on pharmacokinetics of etimicin in healthy volunteers.
    Wang HX; Zhang LR; Ma XC; Ma TX
    Acta Pharmacol Sin; 2002 Apr; 23(4):376-80. PubMed ID: 11931698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
    Sörgel F; Kinzig M
    Eur J Surg Suppl; 1994; (573):39-44. PubMed ID: 7524794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations.
    Liu Q; Rand K; Derendorf H
    Int J Antimicrob Agents; 2004 May; 23(5):494-7. PubMed ID: 15120729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
    Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
    Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA approved new drug bulletin: piperacillin/tazobactam (zosyn), salmeterol xinafoate (serevent).
    RN; 1994 Aug; 57(8):49-52. PubMed ID: 8079096
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
    Bonafede ME; Blumer JL
    Adv Pediatr Infect Dis; 1996; 12():71-108. PubMed ID: 9033976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.